Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ideal Concentration of Ropivacaine with Sufentanil for Thoracic Epidural Analgesia
2004-001285-40Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ropivacaine in postoperative pain, sponsored by Ghent University Hospital. Primary endpoints: VAS pain score at rest and VAS pain score during movement. Started Dec 2005; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2004-001285-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001285-40.